CytoDyn Debt-to-Assets Ratio Growth & History (CYDY)

CytoDyn's debt-to-assets ratio was 1.89 for fiscal 2026.

View full CytoDyn company overview

CytoDyn annual debt-to-assets ratio history

CytoDyn annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20262026-05-311.891.88+24097.10%
20252025-05-310.01−4.06−99.81%
20242024-05-314.07−0.02−0.46%
20232023-05-314.092.62+178.88%
20222022-05-311.471.14+350.76%
20212021-05-310.330.32+9126.50%
20202020-05-310.00−0.17−97.95%
20192019-05-310.170.17
20182018-05-310.00−0.13
20172017-05-310.13
20152015-05-310.01−0.27−96.65%
20142014-05-310.28−0.08−22.11%
20132013-05-310.36

CytoDyn debt-to-assets ratio trends

Over the last five fiscal years, CytoDyn's debt-to-assets ratio increased from 0.33 to 1.89, a change of 1.57. The latest reported quarter, Q4 2026, shows 1.89.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review CytoDyn source filings ↗

Community posts

It’s quiet here.

No posts about CYDY yet. Start the conversation.

Write the first post